NEC OncoImmunity Revenue

Biotechnology Research • Oslo, Oslo, Norway • 21-50 Employees

NEC OncoImmunity revenue & valuation

Annual revenue	$3,500,000
Revenue per employee	$80,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$11,200,000
Total funding	$4,800,000

Key Contacts at NEC OncoImmunity

Saverio Niccolini

Chief Executive Officer

Richard Stratford

Co-Founder And Advisor

Tomoyuki Takaoka

Member Board Of Directors

Company overview

Headquarters	Ullernchausséen 64, Oslo, Oslo 0379, NO
Phone number	+4790015242
Website	nec-bio.com
SIC	873
Keywords	Cancer Immunotherapy, Bioinformatics, Clinical Development, Computational Immunology
Founded	2014
Employees	21-50
Socials

NEC OncoImmunity Email Formats

NEC OncoImmunity uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@nec-bio.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@nec-bio.com	100%

About NEC OncoImmunity

NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning software, which addresses the key gaps in the prediction of bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines. We are dedicated to developing scalable software solutions that facilitate effective patient selection for cancer immunotherapy, and identifying optimal neoantigen targets for truly personalized cancer vaccines & cell therapies in a clinically actionable time frame. Our growing international team (13 countries and counting!) consists of a diverse mix of data scientists, bioinformaticians, immunologists, cancer researchers, and software developers. NEC OncoImmunity AS is a subsidiary of the NEC Corporation, and is based in the Oslo Cancer Cluster buildings in Oslo, Norway.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Senior

Manager

Employees by Department

NEC OncoImmunity has 27 employees across 10 departments.

Departments

Number of employees

Funding Data

Explore NEC OncoImmunity's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-05-08	3	$4,800,000

Funding Insights

$4,800,000

Total funding amount

$4,800,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

NEC OncoImmunity is located in Oslo, Oslo, NO.

You can reach NEC OncoImmunity at +4790015242.

NEC OncoImmunity generates an estimated annual revenue of $3,500,000. This revenue figure reflects the company's market position and business performance in its industry.

NEC OncoImmunity has an estimated valuation of $11,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

NEC OncoImmunity was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

NEC OncoImmunity has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

NEC OncoImmunity has raised a total of $4,800,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.